Sangamo Therapeutics (SGMOQ) Capital Leases (2016 - 2018)
Sangamo Therapeutics (SGMOQ) posted quarterly Capital Leases of $27.7 million for Q4 2018, up 11.93% year-over-year from $24.7 million in Q4 2017, and up 2.83% quarter-over-quarter from $26.9 million in Q3 2018.
Sangamo Therapeutics (SGMOQ) Capital Leases (2016 - 2018) Analysis & Trends
Sangamo Therapeutics' Capital Leases history runs 3 years deep, the most recent figure standing at $27.7 million for Q4 2018.
- In Q4 2018, Capital Leases rose 11.93% year-over-year to $27.7 million; the TTM figure through Dec 2018 stood at $27.7 million (up 11.93% YoY), while the FY2018 annual figure was $27.7 million, up 11.93% from the prior year.
- Capital Leases for Q4 2018 stood at $27.7 million, up from $26.9 million in the prior quarter.
- The five-year high for Capital Leases was $27.7 million in Q4 2018, with the low at $213000.0 in Q1 2016.
- The 3-year median for Capital Leases is $3.9 million (2016), against an average of $12.4 million.
- The sharpest annual moves came in 2017 and 2018: Capital Leases surged 1744.13% in 2017, then increased 11.93% in 2018.
- Sangamo Therapeutics' Capital Leases stood at $3.9 million in 2016, then jumped by 527.07% to $24.7 million in 2017, then gained by 11.93% to $27.7 million in 2018.
- Business Quant data shows SGMOQ's Capital Leases at $27.7 million in Q4 2018, $26.9 million in Q3 2018, and $26.2 million in Q2 2018.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 27.69 Mn |
| Sep 30, 2018 | 26.93 Mn |
| Jun 30, 2018 | 26.18 Mn |
| Mar 31, 2018 | 25.45 Mn |
| Dec 31, 2017 | 24.74 Mn |
| Sep 30, 2017 | 3.87 Mn |
| Jun 30, 2017 | 3.89 Mn |
| Mar 31, 2017 | 3.93 Mn |
| Dec 31, 2016 | 3.95 Mn |
| Sep 30, 2016 | 2.26 Mn |
| Jun 30, 2016 | 247,000.00 |
| Mar 31, 2016 | 213,000.00 |